Legal & General Group
BIVV

Legal & General Group’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Legal & General Group’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-462,996
Closed -$25M – 3301
2017
Q4 		$25M Sell
462,996
-23,873
-5% -$1.31M 0.02% 636
2017
Q3 		$27.8M Buy
486,869
+25,982
+6% +$1.52M 0.02% 619
2017
Q2 		$27.7M Buy
460,887
+20,809
+5% +$1.18M 0.02% 607
2017
Q1 		$24M Buy
+440,078
New +$21.7M 0.02% 624

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Legal & General Group's BIVV Position: Q1 2018 in Review

Legal & General Group sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 462,996 shares — an estimated $25M sold.

Legal & General Group first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $27.8M in Q3 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Legal & General Group reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Legal & General Group sold 462,996 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $25M.
  • Legal & General Group first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Legal & General Group's Bioverativ Inc. Common Stock position peaked at $27.8M in Q3 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Legal & General Group's 13F filing for Q1 2018, filed 17 May 2018.